1. Home
  2. TLIH vs SCYX Comparison

TLIH vs SCYX Comparison

Compare TLIH & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLIH
  • SCYX
  • Stock Information
  • Founded
  • TLIH 1998
  • SCYX 1999
  • Country
  • TLIH Singapore
  • SCYX United States
  • Employees
  • TLIH N/A
  • SCYX N/A
  • Industry
  • TLIH
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TLIH
  • SCYX Health Care
  • Exchange
  • TLIH Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • TLIH 29.1M
  • SCYX 26.6M
  • IPO Year
  • TLIH 2025
  • SCYX 2014
  • Fundamental
  • Price
  • TLIH $0.62
  • SCYX $0.86
  • Analyst Decision
  • TLIH
  • SCYX
  • Analyst Count
  • TLIH 0
  • SCYX 0
  • Target Price
  • TLIH N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • TLIH 1.2M
  • SCYX 212.7K
  • Earning Date
  • TLIH 01-01-0001
  • SCYX 08-19-2025
  • Dividend Yield
  • TLIH N/A
  • SCYX N/A
  • EPS Growth
  • TLIH N/A
  • SCYX N/A
  • EPS
  • TLIH 0.05
  • SCYX N/A
  • Revenue
  • TLIH $42,862,063.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • TLIH N/A
  • SCYX $410.22
  • Revenue Next Year
  • TLIH N/A
  • SCYX $248.83
  • P/E Ratio
  • TLIH $12.59
  • SCYX N/A
  • Revenue Growth
  • TLIH N/A
  • SCYX N/A
  • 52 Week Low
  • TLIH $0.55
  • SCYX $0.66
  • 52 Week High
  • TLIH $7.00
  • SCYX $1.82
  • Technical
  • Relative Strength Index (RSI)
  • TLIH N/A
  • SCYX 65.83
  • Support Level
  • TLIH N/A
  • SCYX $0.68
  • Resistance Level
  • TLIH N/A
  • SCYX $0.92
  • Average True Range (ATR)
  • TLIH 0.00
  • SCYX 0.04
  • MACD
  • TLIH 0.00
  • SCYX 0.02
  • Stochastic Oscillator
  • TLIH 0.00
  • SCYX 77.24

About TLIH Ten-League International Holdings Limited Ordinary Shares

Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: